Heparin Sodium (CAS 101921-26-0) – Anticoagulant API

Heparin Sodium (CAS 101921-26-0) is a high-purity mucopolysaccharide anticoagulant API, extracted from porcine intestinal mucosa and refined via advanced purification processes. Its core mechanism binds to antithrombin III, enhancing the inhibition of thrombin and factor Xa, thereby preventing blood clot formation and reducing thromboembolism risks. Produced under strict GMP-compliant standards, it ensures ultra-low impurity levels, consistent anticoagulant activity, and compliance with international pharmaceutical and clinical standards.

This premium API is a cornerstone raw material for pharmaceutical manufacturers developing thrombosis prevention and treatment medications. It is widely applied in formulating injectable drugs for deep vein thrombosis, pulmonary embolism, and intraoperative anticoagulation, as well as hemodialysis procedures. With proven clinical safety and rapid onset of action, it addresses the critical demand for reliable anticoagulant therapies in cardiovascular care. For R&D teams and production enterprises, it provides a trusted solution to advance thrombotic disease management.